Tandem Diabetes Care, Inc.
TNDM
$22.11
$0.723.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.17% | 8.46% | 22.30% | 43.62% | 31.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.17% | 8.46% | 22.30% | 43.62% | 31.43% |
| Cost of Revenue | -3.65% | 5.23% | 19.60% | 20.96% | 24.46% |
| Gross Profit | 7.73% | 11.58% | 25.07% | 68.77% | 38.88% |
| SG&A Expenses | 6.83% | 16.29% | 16.49% | 20.47% | 25.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.28% | 7.86% | 15.24% | 21.06% | 24.36% |
| Operating Income | 23.11% | -3.53% | 17.24% | 98.43% | 17.28% |
| Income Before Tax | -11.18% | -94.07% | -208.86% | 100.05% | 26.41% |
| Income Tax Expenses | -724.49% | -596.92% | 165.76% | 43.50% | -71.46% |
| Earnings from Continuing Operations | 8.97% | -70.05% | -205.64% | 102.52% | 29.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.97% | -70.05% | -205.64% | 102.52% | 29.46% |
| EBIT | 23.11% | -3.53% | 17.24% | 98.43% | 17.28% |
| EBITDA | 28.85% | -3.10% | 19.80% | 111.06% | 20.49% |
| EPS Basic | 11.81% | -64.84% | -200.67% | 102.48% | 29.91% |
| Normalized Basic EPS | 4.31% | -31.97% | 8.19% | 105.98% | 26.86% |
| EPS Diluted | 11.81% | -64.84% | -200.67% | 102.48% | 29.91% |
| Normalized Diluted EPS | 4.31% | -31.97% | 8.19% | 105.95% | 26.86% |
| Average Basic Shares Outstanding | 3.23% | 3.16% | 1.65% | 0.87% | 0.65% |
| Average Diluted Shares Outstanding | 3.23% | 3.16% | 1.65% | 1.21% | 0.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |